Clinical Trials Directory

We are doing this study to evaluate the accuracy and utility of two remote vital sign monitoring devices, called TempTraq and VitalTraq, when used by blood cancer patients receiving chimeric antigen receptor (CAR) T-cell and bispecific T-cell engager (BiTE) therapies. In the future, these remote vital sign monitoring devices may help with earlier detection and intervention of treatment side effects, including cytokine release syndrome (CRS) and infections.

We are doing this study is to test the effectiveness of a new virtual exercise training program created for older individuals who are living with prediabetes.

We are doing this study to find out if there is a difference in breath analysis between patients with and without rejection after lung transplantation.

We are doing this study is to see if we can predict carotid artery function using wearable technology (for example, a FitBit®).

We are doing this study to test a skills training program that is designed to help people cope with pain. We want to know if this program can help people manage pain after breast surgery. This is important because studies show that between 25% and 60% of people who have breast surgery for cancer or other medical conditions report having persistent pain afterward.

We are doing this study to find out if an experimental drug and device system called X-PACT is a safe and effective treatment for various forms of cancer.

We are doing this study to find out if an experimental drug called XmAb819 (the study drug) is a safe and effective treatment for clear cell renal cell carcinoma (ccRCC).

We are doing this study to learn how to get the best quality images of lungs in an MRI scanner as people breathe in Xenon gas. We hope this imaging will show key differences between diseased and healthy lungs.